GEO-STAR: Telephone Versus In-person Post-test Cancer Genetic Counseling

Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna (Other)
Overall Status
Recruiting
CT.gov ID
NCT04759352
Collaborator
(none)
724
1
2
47.5
15.2

Study Details

Study Description

Brief Summary

The purpose of the GEO-STAR randomized non-inferiority trial is to compare the outcome of post-test telephone cancer genetic counseling with standard in-person cancer genetic counseling. We hypothesize that telephone counseling is non-inferior by outcome if compared to standard in-person counseling.

Condition or Disease Intervention/Treatment Phase
  • Other: Post-test genetic counseling delivered by telephone
N/A

Detailed Description

Consecutive patients undergoing pre-test cancer genetic counseling and cancer genetic testing, during the study period, will be eligible to participate. During the pre-test genetic counseling, demographic data, family and personal medical history will be collected and pedigree will be drawn. Available participants will provide written informed consent. They will be then randomized in blocks of ten participants using an online system (http://wwwservizi.regione.emilia-romagna.it/generatore/).

The study is open label; thus, patients and investigators will not be blinded to treatment allocation due to the study nature intervention.

After randomization, participants will be scheduled for post-test genetic counseling session. Participants randomized to usual care will receive standard in-person result disclosure. Participants randomized to telephone counseling will be scheduled for telephone post-test counseling sessions. One-week after completing the post-test genetic counseling session, the survey package will be sent by email to participants to assess impact and satisfaction with post-test counseling.

Genetic counselors delivering post-test genetic counseling will complete the questionnaire immediately after the post-test session.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
724 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Cancer Genetic Counseling: Telephone Versus Standard In-person Delivery. A Randomized Trial (GEO-STAR)
Actual Study Start Date :
May 15, 2021
Anticipated Primary Completion Date :
Apr 30, 2025
Anticipated Study Completion Date :
Apr 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telephone post-test genetic counseling

Post-test genetic counseling delivered by telephone

Other: Post-test genetic counseling delivered by telephone
Participants enrolled in the experimental arm will receive genetic counseling for test result communication by telephone.

No Intervention: In-person post-test genetic counseling

Post-test genetic counseling delivered in-person

Outcome Measures

Primary Outcome Measures

  1. "Multidimensional Impact of Cancer Risk Assessment" questionnaire [Seven days after the post-test genetic counseling session]

    Impact of post-test counseling on patients. The "Multidimensional Impact of Cancer Risk Assessment" questionnaire measures distress, uncertainty and positive experiences associated to cancer genetic testing. A version adapted to the Italian context will be used, where a single item related to insurance has been removed because not applicable to the Italian Health System. The resulting possible scores range from 0 to 100. Higher scores indicate more negative impacts of cancer risk assessment.

  2. "Patient perceptions of the genetic counseling questionnaire" [Seven days after the post-test genetic counseling session]

    Impact of post-test counseling on patients. The range of scores is from 8 to 31. Higher scores indicate positive perception of the genetic counseling session.

  3. "Genetic Counselor process Questionnaire" [Immediately after the post-test genetic counseling session]

    Professionals perceptions measured by the Genetic Counselor process Questionnaire completed by professionals who provided the post-test genetic counseling. The range of scores is from 4 to 20. Higher scores indicate positive perception of the genetic counselor.

Secondary Outcome Measures

  1. Influence of sociodemographic and medical history on genetic counseling outcomes [Data collection during pre-test genetic counseling session]

    Sociodemographic variables and family and personal cancer history will be collected during the pre-test session.

  2. Impact of logistics on genetic counseling preferences [Data collection during the pre-test genetic counseling session]

    Distance (in kilometers) of patient's primary residence to the clinic location collected by the demographic data collected at pre-test genetic counseling

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients over 18 years of age inclusive at the time of the study;

  • Patients must have undergone an in-person pre-test genetic counseling session;

  • Patients must have undertaken cancer genetic testing;

  • Patients must be able to speak Italian fluently;

  • Patients must have got an email address.

Exclusion Criteria:
  • Patients unable to provide informed consent, for example due to mental incapacity or active psychotic illness.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UO Genetica Medica, IRCCS AOU di Bologna Bologna Italy 40138

Sponsors and Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Daniela Turchetti, Prof., IRCCS Azienda Ospedaliero-Universitaria di Bologna
ClinicalTrials.gov Identifier:
NCT04759352
Other Study ID Numbers:
  • GEO-STAR
First Posted:
Feb 18, 2021
Last Update Posted:
Jul 28, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Daniela Turchetti, Prof., IRCCS Azienda Ospedaliero-Universitaria di Bologna

Study Results

No Results Posted as of Jul 28, 2021